Barclays’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Barclays’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,082,091	Closed	-$212M	–	7577
2014 Q4	$212M	Sell	2,082,091 -846,978	-29%	-$81.2M	0.2%	71
2014 Q3	$252M	Buy	2,929,069 +118,631	+4%	+$10.5M	0.24%	51
2014 Q2	$253M	Buy	2,810,438 +1,926,568	+218%	+$144M	0.27%	47
2014 Q1	$64.5M	Buy	883,870 +259,924	+42%	+$18.1M	0.07%	235
2013 Q4	$42.4M	Buy	+623,946	New	+$40.6M	0.04%	398
2013 Q3	–	Sell	-749,628	Closed	-$45.7M	–	7953
2013 Q2	$41.8M	Buy	+749,628	New	+$43.3M	0.05%	307

Barclays's COV Position: Q1 2015 in Review

Barclays sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,082,091 shares — an estimated $212M sold.

Barclays first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $253M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Barclays reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Barclays sold 2,082,091 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $212M.
Barclays first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
Barclays's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $253M in Q2 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.